Alesia Tietze | Medicinal Chemistry in Cancer | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Alesia Tietze
Affiliation Department of Chemistry and Molecular Biology
Country Sweden
Scopus ID 55193803000
Documents 40
Citations 784
h-index 17
Subject Area Medicinal Chemistry in Cancer
Event Global Genetics Awards
ORCID 0000-0002-9281-548X

Alesia Tietze
Department of Chemistry and Molecular Biology

Alesia Tietze is a researcher affiliated with the Department of Chemistry and Molecular Biology in Sweden, with a research profile identified in the supplied academic information as relating to medicinal chemistry in cancer. The profile is associated with 40 Scopus-indexed documents, 784 citations, and an h-index of 17. These bibliometric indicators provide a quantitative view of research visibility and scholarly impact, while the award assessment itself should be based on the complete research record and independently verified evidence. [3]

Abstract

The Innovative Research Award profile for Alesia Tietze documents a research career represented in the supplied data by an affiliation with the Department of Chemistry and Molecular Biology in Sweden and a subject area of medicinal chemistry in cancer. The associated Scopus record is reported as containing 40 documents, 784 citations, and an h-index of 17. [1] These metrics can be used as supporting indicators of scholarly activity and citation reach, but they do not independently establish the novelty, methodological quality, translational significance, or originality of individual research contributions. The researcher is also associated with an ORCID identifier, providing a persistent identifier for distinguishing the scholarly record. [2]

Keywords

Alesia Tietze; Innovative Research Award; medicinal chemistry; cancer research; chemistry and molecular biology; cancer therapeutics; molecular research; research impact; Scopus; ORCID; Genetics Awards.

Introduction

Medicinal chemistry occupies an interdisciplinary position between chemistry, molecular biology, pharmacology, and therapeutic development. Research in this area may involve the design, synthesis, characterization, optimization, and biological evaluation of compounds intended to address disease-associated molecular targets. In cancer research, medicinal chemistry can intersect with studies of molecular mechanisms, therapeutic targets, biomarkers, drug resistance, and precision-oriented treatment strategies.

Within this broad research environment, academic recognition generally requires consideration of both quantitative and qualitative evidence. Bibliometric indicators such as document counts, citation counts, and h-index values can provide useful measures of scholarly visibility, while publications, methodological contributions, collaborations, and demonstrable scientific outcomes provide additional context. The Genetics Awards program states that submitted research profiles may undergo screening, credential verification, cross-checking of submitted information, and committee review before selection. [3]

Research Profile

The supplied profile identifies Alesia Tietze with the Department of Chemistry and Molecular Biology in Sweden and assigns the subject area of medicinal chemistry in cancer. The reported Scopus information comprises 40 documents, 784 citations, and an h-index of 17. [1] Taken together, these values indicate a documented body of indexed scholarly output and citation activity.

The research profile should be interpreted in relation to the underlying publications rather than as a standalone ranking. Citation indicators can vary according to database coverage, publication type, disciplinary citation practices, author disambiguation, and the date on which the record is consulted. The ORCID identifier supplied for the researcher offers an additional mechanism for connecting scholarly outputs to a persistent researcher identity. [2]

Research Contributions

Based on the supplied subject classification, Tietze’s academic profile is situated within medicinal chemistry in cancer. This field encompasses research that connects chemical science with biological and therapeutic questions relevant to oncology. The precise contribution of an individual researcher should, however, be established from verified publications, research projects, patents, datasets, collaborations, and other primary scholarly evidence rather than inferred solely from a subject-area label.

For an award evaluation, relevant evidence may include the originality of research questions, rigor of experimental or computational methods, reproducibility, significance of findings, contribution to interdisciplinary research, and potential relevance to cancer biology or therapeutic development. The Genetics Awards program identifies research excellence and related scientific contributions among the areas considered within its award framework. [3]

Publications

The supplied Scopus record reports 40 documents associated with the researcher. [1] Because individual publication titles, journals, publication years, authorship positions, and DOI identifiers were not supplied in the source information for this profile, specific publications are not enumerated here. This avoids attributing research findings or bibliographic details that have not been independently established.

For formal award documentation, the publication record can be verified through the researcher’s Scopus author profile and persistent ORCID identifier. Where individual publications are evaluated, DOI metadata should be checked against the publisher or DOI registration record before being included in a nomination dossier.

Research Impact

The supplied bibliometric indicators provide a measurable representation of scholarly impact: 784 citations across 40 reported documents and an h-index of 17. [1] These indicators may support an assessment of sustained research visibility, but they should be interpreted alongside publication quality, contribution to the scientific literature, collaboration, methodological innovation, and the broader significance of the research.

In the context of cancer-focused medicinal chemistry, research impact may also be considered through the extent to which scientific findings contribute to understanding disease mechanisms, identifying therapeutic opportunities, improving molecular tools, or informing subsequent research. Such outcomes require evidence from the underlying scholarly record and should not be inferred solely from citation statistics.

Award Suitability

The supplied profile presents several elements relevant to consideration for an Innovative Research Award: a defined research affiliation, a subject-area focus in medicinal chemistry and cancer, an established indexed publication record, and measurable citation activity. The reported h-index of 17 and 784 citations may serve as supporting bibliometric evidence of scholarly reach. [1]

Final award suitability should remain dependent on the official evaluation process and verification of the nominee’s complete research record. The Genetics Awards program describes a process involving submission screening, verification of credentials, cross-checking of information, committee review, and subsequent selection. [3] Accordingly, the present article should be understood as an academic recognition profile based on the supplied information rather than as an independent declaration of award selection.

Conclusion

Alesia Tietze’s supplied academic profile represents a researcher associated with the Department of Chemistry and Molecular Biology in Sweden and with medicinal chemistry in cancer. The reported Scopus indicators of 40 documents, 784 citations, and an h-index of 17 provide quantitative evidence of an established scholarly record. [1] The associated ORCID identifier further supports persistent scholarly identification. [2]

For the purposes of the Innovative Research Award, these indicators constitute useful supporting evidence but should be considered together with the originality, rigor, significance, and documented outcomes of the researcher’s work. A complete assessment should rely on verified publications and other primary academic evidence in accordance with the award’s stated evaluation procedures. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Alesia Tietze, Author ID 55193803000.

    Scopus.https://www.scopus.com/authid/detail.uri?authorId=55193803000

  2. ORCID. (n.d.). ORCID record: Alesia Tietze, ORCID iD 0000-0002-9281-548X.
    https://orcid.org/0000-0002-9281-548X

  3. Targeted sortase A inhibition by novel peptidomimetic antivirulents against staphylococcal infections

    https://pubmed.ncbi.nlm.nih.gov/41773879/

  4. DNA Scission by Non-Histidine Amino-Terminal Cu(II) and Ni(II) Binding-Like Peptides

    https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.70397

Laila Darwich Soliva | WGS AMR transmission| Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Laila Darwich Soliva
Affiliation Universitat Autònoma de Barcelona
Country Spain
Scopus ID 8514531300
Documents 101
Citations 3,917
h-index 37
Subject Area WGS AMR transmission
Event Global Genetics Awards
ORCID 0000-0001-9027-9452

Laila Darwich Soliva
 Universitat Autònoma de Barcelona

Laila Darwich Soliva is a researcher and academic at the Universitat Autònoma de Barcelona (UAB), Spain, working in animal health, infectious diseases, antimicrobial resistance and One Health research. Her institutional research profile identifies her within the Department of Animal Health and Anatomy and the research group TRANSMISAN. The profile records a substantial body of peer-reviewed research and an h-index of 37. [1]

Abstract

The Innovative Research Award profile recognizes the research activities of Laila Darwich Soliva in the fields of animal health, infectious diseases, antimicrobial resistance and One Health. Her academic work is associated with the Universitat Autònoma de Barcelona, where she is affiliated with the Department of Animal Health and Anatomy and the TRANSMISAN research group. Institutional records describe research outputs addressing bacterial pathogens, antimicrobial-resistance determinants, zoonotic disease and genomic surveillance. [1]

Her research trajectory combines veterinary science with microbiological, epidemiological and genomic approaches. This interdisciplinary orientation is particularly relevant to contemporary surveillance of antimicrobial resistance, where understanding transmission across animal, environmental and human populations requires integrated One Health methodologies. Her publication record and citation indicators provide quantitative evidence of sustained scholarly activity. [1]

Keywords

Laila Darwich Soliva; Innovative Research Award; Universitat Autònoma de Barcelona; antimicrobial resistance; whole-genome sequencing; WGS; AMR transmission; infectious diseases; veterinary medicine; One Health; zoonoses; bacterial genomics; antimicrobial-resistance genes; genomic surveillance; animal health.

Introduction

Darwich Soliva’s research profile is situated within this interdisciplinary environment. UAB records identify her academic activities with the Department of Animal Health and Anatomy and the TRANSMISAN group, while her institutional profile documents research outputs spanning animal infectious diseases, antimicrobial resistance and related One Health topics. [1]

Her academic career also includes formal training in veterinary medicine and postgraduate research experience. The UAB research portal records a PhD in Veterinary Medicine awarded in 2004 and previous postdoctoral research activity at the Germans Trias i Pujol Health Sciences Research Institute. [1]

Research Profile

The research profile of Laila Darwich Soliva reflects an interdisciplinary approach to infectious diseases and animal health. Her institutional affiliation places her within the scientific area of Animal Health, with research activities connected to transmissible diseases and One Health. [1]

  • Veterinary medicine and animal health research.
  • Antimicrobial resistance and antimicrobial-resistance determinants.
  • Whole-genome sequencing and bacterial genomic characterization.
  • Zoonoses and infectious diseases at the animal–human interface.
  • One Health approaches to infectious-disease surveillance.
  • Epidemiological investigation of pathogens in animal and wildlife populations.

The UAB research portal currently lists more than one hundred research outputs associated with her profile, including articles, reviews, book chapters and other scholarly contributions. Recent examples include research on antimicrobial-resistance genes in wildlife and livestock-associated bacteria and genomic characterization of Klebsiella strains. [1]

Research Contributions

A central contribution of Darwich Soliva’s research is the application of genomic and microbiological methods to questions of antimicrobial resistance and infectious-disease transmission. Research listed by UAB includes work examining the global distribution of antimicrobial-resistance genes in Escherichia coli isolated from wild animals, as well as studies of antibiotic determinants and heavy-metal resistance genes in E. coli from pigs in Catalonia. [1]

Her recent research record also includes whole-genome characterization of Klebsiella strains identified in European hedgehogs and human nosocomial settings, with attention to shared sequence types, antimicrobial-resistance genes and plasmids. Such work illustrates the value of genomic comparison for understanding bacterial populations across ecological and clinical contexts. [1]

Additional research activities address antimicrobial resistance in companion-animal and wildlife contexts, including studies of canine otitis pathogens and resistant bacterial populations. These research directions contribute to a broader evidence base for antimicrobial stewardship and surveillance within veterinary and One Health frameworks. [1]

Publications

The institutional research portal lists a substantial publication record for Laila Darwich Soliva. Examples of recent research outputs include peer-reviewed studies addressing antimicrobial resistance, bacterial genomics and wildlife-associated pathogens. [1]

  • Detection of Extended-Spectrum β-Lactamase–Producing Bacteria and CMY-2 Genes in Coypu (Myocastor coypus) in Catalan Wetlands, Northeast Spain, published in the Journal of Wildlife Diseases in 2026. [1]
  • Whole Genome Characterization of Klebsiella Strains in European Hedgehogs and Human Nosocomial Settings Identified Shared Sequence Types, Antimicrobial Resistance Genes and Plasmids, published in Zoonoses and Public Health in 2026. [1]
  • Characterization of antibiotic determinants and heavy metal resistance genes in Escherichia coli from pigs in Catalonia, published in Microbial Genomics in 2025. [1]
  • Global distribution of antimicrobial resistance genes in Escherichia coli isolated from wild animals using genomes available in public databases, published in Science of the Total Environment in 2025. [1]
  • Trends in Antimicrobial Resistance of Canine Otitis Pathogens in the Iberian Peninsula (2010–2021), published in Antibiotics in 2025. [1]

Publication-specific DOI information should be verified against the publisher or DOI registry before being used as a bibliographic identifier. No DOI is asserted here where the supplied researcher profile does not provide a verified DOI value.

Research Impact

The supplied research metrics identify 101 documents, approximately 3,917 citations and an h-index of 37. The UAB research portal independently reports an h-index of 37 and a citation count displayed at approximately 3,931 at the time of its indexed profile, illustrating that citation totals can vary according to database update timing and indexing coverage. [1]

Beyond bibliometric indicators, the research profile has relevance to infectious-disease surveillance, veterinary public health and antimicrobial-resistance monitoring. Studies involving wildlife, livestock, companion animals and bacterial genomic data demonstrate the potential value of integrated surveillance approaches for identifying resistance determinants and understanding pathogen circulation across populations. [1]

Her academic activities also extend into postgraduate and multidisciplinary education. The UAB Master’s Degree in Zoonoses and One Health identifies Laila Darwich Soliva as coordinator and teaching staff member, reflecting an educational role connected with multidisciplinary approaches to zoonotic disease and One Health. [2]

Award Suitability

The research record provides a substantive basis for consideration under an Innovative Research Award framework. Relevant factors include sustained scholarly output, a documented research focus on infectious diseases and antimicrobial resistance, application of genomic approaches to bacterial surveillance, and participation in multidisciplinary One Health education and research. [1] [2]

  • Research relevance: Her work addresses antimicrobial resistance, infectious diseases and animal health, areas of continuing scientific and public-health importance.
  • Methodological scope: Her research includes genomic characterization and whole-genome sequencing approaches relevant to bacterial surveillance.
  • Interdisciplinary contribution: The research connects veterinary medicine, microbiology, epidemiology, genomics and One Health.
  • Scholarly record: The institutional profile documents a substantial body of research output and established citation impact. [1]
  • Educational contribution: Her involvement in the UAB Zoonoses and One Health master’s programme demonstrates engagement with multidisciplinary scientific education. [2]

Award suitability remains subject to the formal evaluation criteria, documentation requirements and independent review procedures established by the Genetics Awards programme. The information presented here should therefore be regarded as an academic recognition profile rather than a determination of award outcome.

Conclusion

Laila Darwich Soliva’s academic profile represents sustained research activity in animal health, infectious diseases, antimicrobial resistance and One Health. Her work incorporates genomic and epidemiological perspectives that are increasingly important for understanding antimicrobial-resistance patterns and pathogen transmission across animal and human environments. [1]

The combination of research productivity, citation impact, interdisciplinary investigation and academic engagement provides a strong scholarly context for consideration for an Innovative Research Award. Her institutional record further demonstrates involvement in postgraduate education and multidisciplinary One Health training. [1] [2]

References

  1. Universitat Autònoma de Barcelona. (n.d.). Laila Darwich Soliva — Research Portal. Department of Animal Health and Anatomy; Grup de Recerca en Malalties Transmissibles en Sanitat Animal (TRANSMISAN).

    https://portalrecerca.uab.cat/en/persons/laila-darwich-soliva-7/

  2. Evolution and Antimicrobial Resistance Profiles of Klebsiella spp. Infections in Companion Animals in the Iberian Peninsula

    https://www.mdpi.com/2079-6382/15/7/678

  3. Detection of Extended-Spectrum β-Lactamase–Producing Bacteria and CMY-2 Genes in Coypu (Myocastor coypus) in Catalan Wetlands, Northeast Spain
    https://pubmed.ncbi.nlm.nih.gov/41698668/

  4. Elsevier. (n.d.). Scopus author details: Laila Darwich Soliva, Author ID 8514531300.

    Scopus.https://www.scopus.com/pages/authors/8514531300

Stephanie Tuminello | Genetic Epidemiology | Innovative Research Award

Published on by Global Genetics Award

 

Innovative Research Award

Stephanie Tuminello
Icahn School of Medicine at Mount Sinai

Stephanie Tuminello
Affiliation Icahn School of Medicine at Mount Sinai
Country United States
Scopus ID 57193871243
Documents 60
Citations 1,069
h-index 15
Subject Area Genetic Epidemiology
Event Global Genetics Awards

Stephanie Tuminello is affiliated with the Icahn School of Medicine at Mount Sinai, where her scholarly work contributes to the advancement of genetic epidemiology and related biomedical research. Her publication record, citation performance, and sustained research activity demonstrate continued engagement in understanding genetic determinants of disease, epidemiological methodologies, and translational biomedical science. Bibliometric indicators from Scopus show a substantial scholarly contribution supported by peer-reviewed publications and academic citations, reflecting the influence of her research within the international scientific community.[1]

Abstract

Stephanie Tuminello’s research portfolio focuses on genetic epidemiology through the integration of population-based investigation, molecular genetics, and clinical data analysis. Her scientific work contributes to understanding disease susceptibility, inherited genetic variation, and risk prediction using evidence-based epidemiological methodologies. The body of published literature demonstrates interdisciplinary collaboration and continued scientific productivity across multiple areas of biomedical research.[1]

Keywords

Genetic Epidemiology; Population Genetics; Human Genetics; Disease Susceptibility; Precision Medicine; Genomic Medicine; Epidemiological Research; Translational Medicine.

Introduction

Genetic epidemiology combines principles from genetics, epidemiology, and biostatistics to evaluate inherited and environmental influences on disease occurrence. Researchers working within this discipline investigate genetic risk factors, gene-environment interactions, and population-level disease patterns to improve healthcare outcomes. Stephanie Tuminello’s scholarly activities align with these objectives through peer-reviewed research that contributes to the broader understanding of genetic determinants of human health.[2]

Research Profile

According to publicly available bibliometric information, Stephanie Tuminello has authored 60 indexed publications that have collectively received more than one thousand citations, resulting in an h-index of 15. These indicators suggest sustained scholarly productivity and measurable research influence within biomedical sciences and genetic epidemiology.[1]

  • Affiliation: Icahn School of Medicine at Mount Sinai
  • Primary discipline: Genetic Epidemiology
  • Scopus-indexed publications: 60
  • Scopus citations: 1,069
  • Scopus h-index: 15

Research Contributions

The available publication record indicates contributions involving genetic risk assessment, epidemiological analysis, disease association studies, clinical research methodologies, and collaborative biomedical investigations. Such work supports improved understanding of disease mechanisms and facilitates evidence generation for future precision medicine initiatives.[1][3]

  • Population-based genetic investigations.
  • Clinical and translational epidemiological research.
  • Genetic susceptibility and disease association studies.
  • Interdisciplinary collaboration across biomedical sciences.

Publications

The author’s publication portfolio consists of peer-reviewed journal articles indexed by major scholarly databases. These publications collectively address topics within genetics, epidemiology, biomedical science, and translational research, demonstrating continued scientific productivity over multiple years.[1]

  • Research articles indexed in Scopus.
  • Collaborative multidisciplinary publications.
  • Biomedical and genetic epidemiology studies.

Research Impact

Bibliometric evidence indicates measurable academic influence through citations, publication output, and scholarly visibility. Citation metrics suggest that the published work has contributed to ongoing scientific discussions and has been referenced by researchers working in related biomedical disciplines. Such indicators are commonly employed in evaluating scientific productivity and research influence.[1]

Award Suitability

Stephanie Tuminello demonstrates characteristics generally considered during evaluation for an Innovative Research Award, including sustained publication activity, measurable citation impact, interdisciplinary collaboration, and contributions to genetic epidemiology. Recognition within an academic awards program would appropriately acknowledge continued scientific engagement while reflecting objective scholarly indicators rather than subjective assessments of scientific merit alone.[1]

Conclusion

Stephanie Tuminello has established an active academic profile through contributions to genetic epidemiology, peer-reviewed publications, and collaborative biomedical research. Publicly available bibliometric indicators demonstrate sustained scholarly productivity and research visibility, supporting recognition within academic and professional award programs dedicated to scientific excellence and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Stephanie Tuminello, Author ID 57193871243.
    Scopus.https://www.scopus.com/authid/detail.uri?authorId=57193871243
  2. Disparities in COVID-19 testing and positivity in New York City
    https://www.sciencedirect.com/science/article/pii/S0749379720302634
  3. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
    https://www.nature.com/articles/ncomms14922
  4. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City
    https://journal.chestnet.org/article/S0012-3692(20)34288-4/fulltext
  5. The impact of asthma on mortality in patients with COVID-19
    https://journal.chestnet.org/article/S0012-3692(20)31645-7/fulltext

 

 Andrea Manica | Population genetics software | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Andrea Manica
Affiliation University of Cambridge
Country United Kingdom
Scopus ID 6603416293
Documents 187
Citations 17,182
h-index 67
Subject Area Population genetics software
Event Global Genetics Awards
ORCID 0000-0003-1895-450X

 Andrea Manica

University of Cambridge, United Kingdom

The Innovative Research Award recognizes sustained scholarly excellence and significant contributions to scientific advancement. Andrea Manica, a researcher at the University of Cambridge, has established an internationally recognized research profile in evolutionary biology, population genetics, human migration, ecological modelling, and computational approaches to biodiversity research. His scholarly publications, extensive citation record, and interdisciplinary collaborations demonstrate continued influence across genetics and evolutionary sciences.[1]

Abstract

Andrea Manica’s research integrates population genetics, ecology, anthropology, computational biology, and evolutionary theory to investigate biological diversity and human evolutionary history. His work combines large-scale genomic datasets, ecological modelling, and statistical methods to improve understanding of species distributions, migration processes, adaptation, and conservation. His scholarly achievements have resulted in a substantial international research profile with extensive citations and broad interdisciplinary impact.[1][2]

Keywords

Population genetics, evolutionary biology, ecological modelling, biodiversity, human migration, computational biology, conservation genetics, statistical ecology, genomics, species distribution modelling.

Introduction

Modern genetics increasingly relies upon interdisciplinary analytical approaches capable of integrating molecular, ecological, and computational evidence. Andrea Manica’s research exemplifies this trend by combining quantitative analysis with evolutionary theory to address questions concerning biodiversity, adaptation, and demographic history. His work has contributed to both methodological development and biological discovery while supporting evidence-based conservation research.[2]

Research Profile

Andrea Manica is affiliated with the University of Cambridge and maintains an internationally visible publication record indexed in Scopus. His documented scholarly metrics include 187 indexed publications, over 17,000 citations, and an h-index of 67, reflecting consistent scientific influence across multiple research disciplines.[1]

  • Population genetics and demographic inference.
  • Human evolutionary history.
  • Ecological and environmental modelling.
  • Biodiversity and conservation science.
  • Statistical and computational biology.

Research Contributions

His investigations have improved scientific understanding of how evolutionary processes, environmental factors, and migration shape genetic diversity. By integrating computational simulations with empirical observations, his studies have informed research concerning adaptation, population structure, climate influences, and conservation planning.[2][3]

  • Development of computational approaches for population genetics.
  • Analysis of human migration and demographic history.
  • Research supporting biodiversity conservation.
  • Integration of ecological and genomic datasets.
  • Interdisciplinary collaboration across genetics and ecology.

Publications

Andrea Manica has authored numerous peer-reviewed publications appearing in internationally recognized scientific journals. His research articles are frequently cited within genetics, ecology, anthropology, conservation biology, and evolutionary science, reflecting sustained scholarly relevance.[1]

  • Population genetic analyses.
  • Evolutionary modelling studies.
  • Human demographic history research.
  • Biodiversity conservation publications.

Research Impact

The documented citation metrics indicate extensive international recognition of Andrea Manica’s scholarly work. His publications continue to support research across genetics, ecology, anthropology, and environmental sciences while influencing computational methodologies and conservation strategies. The breadth of citations reflects continued relevance across diverse scientific communities.[1]

Award Suitability

Based on publicly available scholarly indicators, Andrea Manica demonstrates characteristics consistent with recognition through an Innovative Research Award. These include a sustained publication record, internationally recognized citation impact, interdisciplinary scientific contributions, methodological innovation, and continued advancement of population genetics and evolutionary biology research. Such accomplishments align with common evaluation criteria used in academic recognition programs.[1]

Conclusion

Andrea Manica’s scholarly career reflects substantial contributions to population genetics, computational biology, biodiversity research, and evolutionary science. Through interdisciplinary collaboration and quantitative innovation, his work has strengthened scientific understanding of biological diversity and evolutionary processes. His documented academic achievements support recognition within international research award programs dedicated to scientific excellence and innovation.[2]

References

    1. Elsevier. (n.d.). Scopus author details: Andrea Manica, Author ID 6603416293. Scopus.https://www.scopus.com/authid/detail.uri?authorId=6603416293
    2. ORCID. (n.d.). Andrea Manica
      ORCID Profile.      https://orcid.org/0000-0003-1895-450X
    3. Manica, A., et al. Representative research publication. Nature.
      DOI:
      https://doi.org/10.1038/nature06258
    4. Elsevier. (n.d.). Google scholar details: Andrea Manica.
      Google scholar. https://scholar.google.com/citations?user=v8V058QAAAAJ&hl=en
    5. An African origin for the intimate association between humans and Helicobacter pylori
       https://www.nature.com/articles/nature05562

Yuhui Sun | Gene Therapy | Excellence in Research

Published on by Global Genetics Award

Prof. Dr. Yuhui Sun | Gene Therapy | Excellence in Research

Huazhong University of Science and Technology | China

Prof. Dr. Yuhui Sun is a Professor at Huazhong University of Science and Technology, China. He received his Ph.D. from Shanghai Jiao Tong University and conducted postdoctoral research at the University of Cambridge in Professor Peter F. Leadlay’s group. He served as a Professor at Wuhan University before joining HUST. His research focuses on microbial natural product discovery, biosynthesis, and the development of advanced genetic and genome-editing tools, particularly CRISPR-Cas9–based base editors. Professor Sun has led eight major national and provincial research projects, published 69 SCI-indexed papers with an H-index of 25 and over 1,900 citations, authored a Springer Nature book chapter, and holds nine international and Chinese patents. He has extensive industry collaboration experience, serves on multiple international editorial boards, and is a Fellow of the Royal Society of Chemistry (UK). Internationally recognized for elucidating complex biosynthetic mechanisms and creating hybrid microbial medicines, he has also developed widely adopted genome-editing technologies shared with over 80 research groups worldwide.

Citation Metrics (Scopus)

2400
1800
1200
  600
  0

Citations
2,070

Documents
72

h-index
27

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Changcai Teng | Molecular genetics | Research Excellence Award

Published on by Global Genetics Award

Prof. Dr. Changcai Teng | Molecular genetics | Research Excellence Award

Academy of Agriculture and Forestry, Qinghai university | China

Prof. Dr. Changcai Teng, born on 27 May 1982, is a Chinese crop genetics and breeding specialist currently serving as a Faba Bean Breeder at the Qinghai Academy of Agriculture and Forestry Science and Qinghai University’s Academy of Agriculture and Forestry. He holds a PhD (2018) and MSc (2009) in crop genetics and breeding, as well as a postgraduate qualification in forestry science (2004), all from Qinghai University in Xining, China. With professional experience spanning roles at the Agricultural Technology Promotion Center in Gonghe County and the Sino-Canada joint venture Jason Group Corporation Luyuan Ecology Co., Ltd, his research has focused on the genetics and breeding of Spring Brassica napus, potato, and faba bean. Proficient in Chinese and English, he is based in Xining, Qinghai Province.

Profiles: Scopus 

Featured Publications

"Genome-wide identification of the MADS-box gene family and their role in the formation of faba bean (Vicia faba L.) growth habits", Prof. Dr. Changcai Teng., 2025

Melesse Tadesse | Molecular Genetics | Excellence Award

Published on by Global Genetics Award

Mr. Melesse Tadesse | Molecular Genetics | Excellence Award

University Of Wolaita Sodo | Ethiopia

Mr. Melesse Tadesse Upa (MSc), a highly dedicated Ethiopian biotechnologist, currently serves as the Head and Senior Lecturer in the Department of Biotechnology at Wolaita Sodo University, Ethiopia, where he has been contributing since 2021 after earlier roles as a Biology teacher in Dawro zone. Born on 28 July 1995 in Essera Wereda of the Dawro zone, he holds an MSc in Biotechnology from Arba Minch University, a B.Sc. in Biology and a Postgraduate Diploma in Teaching from Hawassa University, complemented by extensive professional certifications including a Higher Diploma License, English proficiency, GIS tools (ArcGIS, QGIS, Python), and a Master Class in Online Teaching. His research interests span food microbiology, microbial physiology, traditional toxicology, molecular food microbiology, soil microbiology, microbial ecology, bacterial wilt disease, toxicogenomics, heavy metal–gene–protein interactions, and metabolite analysis from medicinal plants. With strong skills in laboratory and fieldwork, molecular techniques, biostatistics, fermentation engineering, microscopy, plant tissue culture, and advanced data analysis tools (SPSS, Origin, GIS), he has taught a wide range of undergraduate biotechnology and biology courses including Molecular Biology, Environmental Biotechnology, Industrial Biotechnology, and Microbial Biotechnology. Melesse is an articulate and highly motivated scientist known for his ability to work under pressure, communicate research outputs effectively, and lead innovative laboratory research collaborations. His MSc thesis focused on isolating and evaluating fermenting microorganisms from enset (kocho) as potential starter cultures, and he has published on the physicochemical and microbial community dynamics of kocho fermentation. He is proficient in English and Amharic and is supported by strong professional references from established researchers at Arba Minch University.

Profiles: Orcid | Google Scholar

Featured Publications

"Recent Advances in Enzyme Immobilization: The Role of Artificial Intelligence, Novel Nanomaterials, and Dynamic Carrier Systems", M Tadesse, Y Liu Catalysts., 2025.

"Physicochemical and microbial community dynamics of Kocho fermented from different enset varieties in South West Ethiopia", M Tadesse, FO Ajibade, M Minale, A Mekonnen, A Guadie Heliyon., 2025.

Bin Zhang | Gene Mutation | Best Researcher Award

Published on by Global Genetics Award

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.

PROFESSIONAL ENDEAVORS

In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE MUTATION

Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.

IMPACT AND INFLUENCE

The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.

ACADEMIC CITES

Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.

LEGACY AND FUTURE CONTRIBUTIONS

Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research

NOTABLE PUBLICATIONS

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis 2023(7)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53 2023(4)

Therapeutic Efficacy of Mesenchymal Stem/Stromal Cell Small Extracellular Vesicles in Alleviating Arthritic Progression by Restoring Macrophage Balance 2023(1)

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines 2024

Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling 2024